Evidence map›Paper›PMID 21761138›Full record

SynthesisHuman genetics2012

Meta-analysis of new genome-wide association studies of colorectal cancer risk.

Ulrike Peters, Carolyn M Hutter, Li Hsu, Fredrick R Schumacher, David V Conti, Christopher S Carlson, Christopher K Edlund, Robert W Haile, Steven Gallinger, Brent W Zanke and 48 more

Open access · greenAbstract readMeta-Analysis
In one paragraph

Synthesis in Human genetics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 143 papers, 17 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
143citing papers in PubMed, 17 pooled it
14.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

143 citing papers in PubMed, 17 syntheses or guidelines pooled it, 207 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Pooled it
  15. Pooled it
  16. Pooled it
  17. Pooled it
  18. Trial
  19. Trial
  20. Trial

83 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

58 authors at 20 institutions in 7 countries.

Ulrike PetersCancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, USA. upeters@fhcrc.org
Carolyn M Hutter
Li Hsu
Fredrick R Schumacher
David V Conti
Christopher S Carlson
Christopher K Edlund
Robert W Haile
Steven Gallinger
Brent W Zanke
Mathieu Lemire
Jagadish Rangrej
Raakhee Vijayaraghavan
Andrew T Chan
Aditi Hazra
David J Hunter
Jing Ma
Charles S Fuchs
Edward L Giovannucci
Peter Kraft
Yan Liu
Lin Chen
Shuo Jiao
Karen W Makar
Darin Taverna
Stephen B Gruber
Gad Rennert
Victor Moreno
Cornelia M Ulrich
Michael O Woods
Roger C Green
Patrick S Parfrey
Ross L Prentice
Charles Kooperberg
Rebecca D Jackson
Andrea Z Lacroix
Bette J Caan
Richard B Hayes
Sonja I Berndt
Stephen J Chanock
Robert E Schoen
Jenny Chang-Claude
Michael Hoffmeister
Hermann Brenner
Bernd Frank
Stéphane Bézieau
Sébastien Küry
Martha L Slattery
John L Hopper
Mark A Jenkins
Loic Le Marchand
Noralane M Lindor
Polly A Newcomb
Daniela Seminara
Thomas J Hudson
David J Duggan
John D Potter
Graham Casey
Fred Hutch Cancer Center · USHarvard University · USUniversity of Southern California · USMemorial University of Newfoundland · CATranslational Genomics Research Institute · USCentre Hospitalier Universitaire de Nantes · FRGerman Cancer Research Center · DEHeidelberg University · DENational Institutes of Health · USOntario Institute for Cancer Research · CAUniversity of Melbourne · AUUniversity of Washington · USBoston University · USBrigham and Women's Hospital · USCarmel Medical Center · ILInstitut Català d'Oncologia · ESKaiser Permanente · USMayo Clinic · USNational Cancer Institute · USNew York University · US

Funding

Translational Bioimaging Core Shared ResourceP30CA015704 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Eric Collisson · 1985 to 2026
$296.4M
Statistical MethodsP01CA087969 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI ROSNER, BERNARD A · 2000 to 2019
$77.8M
Validity of Diet and Activity Measures in WomenP01CA055075 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI GIOVANNUCCI, EDWARD · 1991 to 2009
$41.8M
Pilot & Feasibility ProgramP30DK043351 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI RAYMOND T CHUNG · 1991 to 2026
$35.3M
Tissue and Pathology ResourcesP50CA127003 · NCI · DANA-FARBER CANCER INST · PI BASS, ADAM JOEL · 2007 to 2023
$33.2M
JH/CIDR Genotyping for Genome-Wide Association StudiesU01HG004438 · NHGRI · JOHNS HOPKINS UNIVERSITY · PI VALLE, DAVID · 2007 to 2011
$24.2M
Molecular pathological epidemiology of colorectal cancerU01CA137088 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI PETERS, ULRIKE · 2009 to 2018
$21.8M
USC Consortium:Colorectal Cancer Family RegistryU01CA074799 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI HAILE, ROBERT WILLIAM · 1997 to 2008
$20.4M
SEATTLE FAMILIAL COLORECTAL CANCER REGISTRYU01CA074794 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI NEWCOMB, POLLY A · 1997 to 2007
$14.1M
ONTARIO REGISTRY FOR STUDIES OF FAMILIAL COLON CANCERU01CA074783 · NCI · CANCER CARE ONTARIO · PI GALLINGER, STEVEN · 1997 to 2008
$12.5M
Genome-Wide Association Study of Nonsynonymous SNPs in Colon CancerR01CA059045 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI PETERS, ULRIKE · 1994 to 2011
$11.5M
Transdisciplinary Studies of Genetic Variation in Colorectal CancerU19CA148107 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI GRUBER, STEPHEN B · 2010 to 2014
$11.1M
Intramural NIH HHS Z01 CP010200NCI NIH HHS P01 CA055075NCI NIH HHS P01 CA087969NCI NIH HHS P30 CA015704NCI NIH HHS P50 CA127003NCI NIH HHS R01 CA048998NCI NIH HHS R01 CA059045NCI NIH HHS R01 CA081488NCI NIH HHS R01 CA137178NCI NIH HHS R25 CA094880NCI NIH HHS U01 CA074783NCI NIH HHS U01 CA074794NCI NIH HHS U01 CA074799NCI NIH HHS U01 CA074800NCI NIH HHS U01 CA074806NCI NIH HHS U01 CA097735NCI NIH HHS U01 CA122839NCI NIH HHS U01 CA137088NCI NIH HHS U19 CA148107NCI NIH HHS U24 CA074783NCI NIH HHS U24 CA074799NCI NIH HHS U24 CA074800NCI NIH HHS U24 CA074806NCI NIH HHS U24 CA097735NHGRI NIH HHS U01 HG004438NHGRI NIH HHS U01 HG004446NHLBI NIH HHS N01 WH042131NIA NIH HHS R01 AG014358NIDDK NIH HHS P30 DK043351NIGMS NIH HHS R01 GM108711Wellcome TrustWHI NIH HHS N01 WH022110WHI NIH HHS N01 WH024152WHI NIH HHS N01 WH032100WHI NIH HHS N01 WH032101WHI NIH HHS N01 WH032102WHI NIH HHS N01 WH032105WHI NIH HHS N01 WH032106WHI NIH HHS N01 WH032108WHI NIH HHS N01 WH032109WHI NIH HHS N01 WH032111WHI NIH HHS N01 WH032112WHI NIH HHS N01 WH032113WHI NIH HHS N01 WH032115WHI NIH HHS N01 WH032118WHI NIH HHS N01 WH032119WHI NIH HHS N01 WH032122WHI NIH HHS N01 WH042107WHI NIH HHS N01 WH042108WHI NIH HHS N01 WH042109WHI NIH HHS N01 WH042110WHI NIH HHS N01 WH042111WHI NIH HHS N01 WH042112WHI NIH HHS N01 WH042113WHI NIH HHS N01 WH042114WHI NIH HHS N01 WH042115WHI NIH HHS N01 WH042116WHI NIH HHS N01 WH042117WHI NIH HHS N01 WH042118WHI NIH HHS N01 WH042119WHI NIH HHS N01 WH042120WHI NIH HHS N01 WH042121WHI NIH HHS N01 WH042122WHI NIH HHS N01 WH042123WHI NIH HHS N01 WH042124WHI NIH HHS N01 WH042125WHI NIH HHS N01 WH042126WHI NIH HHS N01 WH042129WHI NIH HHS N01 WH042130WHI NIH HHS N01 WH042132WHI NIH HHS N01 WH044221
6 · The paper itself

Abstract

Colorectal cancer is the second leading cause of cancer death in developed countries. Genome-wide association studies (GWAS) have successfully identified novel susceptibility loci for colorectal cancer. To follow up on these findings, and try to identify novel colorectal cancer susceptibility loci, we present results for GWAS of colorectal cancer (2,906 cases, 3,416 controls) that have not previously published main associations. Specifically, we calculated odds ratios and 95% confidence intervals using log-additive models for each study. In order to improve our power to detect novel colorectal cancer susceptibility loci, we performed a meta-analysis combining the results across studies. We selected the most statistically significant single nucleotide polymorphisms (SNPs) for replication using ten independent studies (8,161 cases and 9,101 controls). We again used a meta-analysis to summarize results for the replication studies alone, and for a combined analysis of GWAS and replication studies. We measured ten SNPs previously identified in colorectal cancer susceptibility loci and found eight to be associated with colorectal cancer (p value range 0.02 to 1.8 × 10(-8)). When we excluded studies that have previously published on these SNPs, five SNPs remained significant at p < 0.05 in the combined analysis. No novel susceptibility loci were significant in the replication study after adjustment for multiple testing, and none reached genome-wide significance from a combined analysis of GWAS and replication. We observed marginally significant evidence for a second independent SNP in the BMP2 region at chromosomal location 20p12 (rs4813802; replication p value 0.03; combined p value 7.3 × 10(-5)). In a region on 5p33.15, which includes the coding regions of the TERT-CLPTM1L genes and has been identified in GWAS to be associated with susceptibility to at least seven other cancers, we observed a marginally significant association with rs2853668 (replication p value 0.03; combined p value 1.9 × 10(-4)). Our study suggests a complex nature of the contribution of common genetic variants to risk for colorectal cancer.

Indexed as

Genome-Wide Association StudyColorectal NeoplasmsFemaleGenetic Predisposition to DiseaseHumansMaleOdds RatioPolymorphism, Single NucleotideRisk Factors

Identifiers

PMID21761138
PMCPMC3257356
OpenAlexW2048352123

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.